INS19 CAR-T Cells for the Treatment of Relapsed or Refractory Acute B Lymphoblastic Leukemia

NCT06209671 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia, B-cell

Interventions

BIOLOGICAL: INS19 CAR-T Cells

Sponsor

Beijing Immunochina Medical Science & Technology Co., Ltd.

Collaborators

[object Object]